NAD+
Also known as: Nicotinamide Adenine Dinucleotide, NAD, β-NAD+
NAD+ is a fundamental coenzyme involved in over 500 enzymatic reactions, particularly those governing cellular energy (ATP production), DNA repair, gene expression, and circadian rhythm regulation. As a direct IV/subcutaneous supplement, it rapidly replenishes intracellular NAD+ pools — addressing the root cause of mitochondrial dysfunction, accelerated aging, and metabolic decline.
Regulatory & Approval Status
NAD+ is currently being investigated in various clinical trials for conditions like metabolic and neurodegenerative disorders, but it is not an FDA-approved drug.
Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.